Clinical Trials Directory

Trials / Completed

CompletedNCT04706000

Autophagy Markers in Endometrial Polyps

Investigation of Autophagy Markers in Endometrial Polyps

Status
Completed
Phase
Study type
Observational
Enrollment
30 (actual)
Sponsor
Muğla Sıtkı Koçman University · Academic / Other
Sex
Female
Age
35 Years
Healthy volunteers
Accepted

Summary

The aim of this research is to evaluate autophagy markers in patients with endometrial polyps

Detailed description

Endometrial polyp are benign formations that are frequently encountered in gynecology practice and have malignant potential. It may be asymptomatic in the clinic or may present with abnormal uterine bleeding. Although its pathophysiology has not been clearly revealed, there are many studies in the literature about it. However, the autophagy pathway emerges as a subject that has never been evaluated. In this study, the investigators would like to prospectively evaluate Beclin 1, LC3A / B and p62 markers in the autophagy pathway in endometrial polyp tissue samples by immunohistochemistry and reveal their importance.

Conditions

Interventions

TypeNameDescription
GENETICBeclin 1 geneThe determination of Beclin 1, LC3-II and p62 genes, which are evaluated by immunohistochemistry, at the protein level will be done by ELISA method in MSKU Medical Faculty Medical Biology Laboratory.

Timeline

Start date
2021-01-08
Primary completion
2022-01-08
Completion
2022-02-01
First posted
2021-01-12
Last updated
2023-12-06

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT04706000. Inclusion in this directory is not an endorsement.